Characterization and Inhibitor Development of the Mammalian N-end Rule Pathway PACCON 2013 Jan. 24, 2013 Min Jae Lee Department of Applied Chemistry College.

Slides:



Advertisements
Similar presentations
The influence of disulfiram complex with copper (CuEt) on cellular proteasome in breast cancer cell lines Skrott Z 1*, Dou QP 2, Cvek B 1, 1 Department.
Advertisements

The mechanism of toxicity of Norspermidine in Arabidopsis Sayas E 1*, Alabadí D 1, del Pozo JC 2, Ferrando A 1, Serrano R 1 1 Instituto de Biología Molecular.
[Vierstra, 2003 TIPS].
MAP kinase Pathways in Yeast How are signals specified between pathways that share Common components? MAP = mitogen activated protein kinase.
The Inner Life of the Cell
Molecular Graphics Perspective of Protein Structure and Function.
Amino Acids: Disposal of Nitrogen
SIGNALING FROM THE CELL SURFACE TO THE NUCLEUS
Intracellular Protein Degradation Chris Weihl MD/PhD Department of Neurology.
The ubiquitin system and a putative stimulatory role for activator turnover in gene expression Chao Wang Nov 16, 2005.
Simon Duri Xixi Hong Joseph Lustig Aleksandra Porebska.
The ubiquitin-proteasome system and its role in the cell cycle
Chemical Genomics – Biol503 Lecture 2 Chemical Genomics and cancer/cardiovascular diseases.
Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family Borodovsky A, Ovaa H, Kolli N, Gan-Erdene T, Wilkinson.
Rapid detection of drugs for protein misfolding diseases. Alexey Krasnoslobodtsev, Department of Pharmaceutical Sciences, University of Nebraska Medical.
Biol518 Lecture 2 HTS and Antibiotic Drug Discovery.
Apoenzyme – the polypeptide portion of an enzyme
Anusorn Cherdthong, PhD Applied Biochemistry in Nutritional Science E-learning:
IMiDs Mechanism of Action and Future Applications
GREAT CHANGES IN HEALTH CARE IN THE PAST 40 YEARS Large increase in life expectancy Great improvements in prevention of disease ( cardiovascular: statins,
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
Protein Metabolism 1  Denotes the various biochemical processes responsible for the synthesis of proteins and amino acids tthe breakdown of proteins.
Protein Structure. Protein Structure I Primary Structure.
Lactacystin: An Inhibitor in the Ubiquitin Proteasome Pathway Ami Jun-Yee Chin February 17, 2005.
Biotechnology in Medicine Chapter 12.
Why this research? Proteasome activity before now measured with isolated 20S subunit – no 19S involvement Proteasome activity before now measured with.
Phenotypic Characterization of lrb Mutants in Arabidopsis thaliana. Brandon D. Blaisdell 1, Matthew Christians 2, Derek J. Gingerich 1 1 Department of.
Enzyme Catalysis 28 October 2014 Katja Dove PhD Candidate, Department of Biochemistry, University of Washington Please.
RA190 Small Molecule Proteasome Inhibitor for Cancer Therapy.
Quantification of Membrane and Membrane- Bound Proteins in Normal and Malignant Breast Cancer Cells Isolated from the Same Patient with Primary Breast.
Samudrala group - overall research areas CASP6 prediction for T Å C α RMSD for all 70 residues CASP6 prediction for T Å C α RMSD for all.
From the Cradle to the grave: molecular chaperones that may choose between folding and degradation By: Erica Zakhem.
CHMI E.R. Gauthier, Ph.D. 1 CHMI 2227E Biochemistry I Enzymes: - Regulation.
Engineering Biosensors for the Sensitive Detection of Proteases Akshay Sriprasad PI: Dr. Indraneel Ghosh, Department of Chemistry Mentor: Sujan Shekhawat.
Cytoplasmic regulation lifetime localization initiation.
Discovery of Therapeutics to Improve Quality of Life Ram Samudrala University of Washington.
The role of the ubiquitin-proteasome pathway in rhTRIM5α-mediated restriction of HIV-1 Cindy Danielson Thomas Hope Laboratory, Northwestern University.
The “conventional” proteasome --33 components, all integral subunits --Extremely conserved among eukaryotes --20 years of biochemistry.
Activity Enhancement of the Synthetic Syrbactin Proteasome Inhibitor Hybrid and Biological Evaluation in Tumor Cells Crystal R. Archer, Michael Groll,
Regulation of Gene expression
מעבדה בביוכימיה לתלמידי ביולוגיה - כימיה (72344) מרכז הקורס : ד " ר תומר רביד עוזרי הוראה : איתמר כהן איילה.
Aspirin Inhibits Cycloxygenase
Protein Degradation BL Proteins have variable life-spans EnzymeHalf-lifeHours Ornithine decarboxylase0.2 RNA polymerase I1.3 Tyrosine aminotransferase2.0.
A novel site for ubiquitination: the N ‐ terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein.
Analysis Of Microarray Data By Harsha Nilakantan & Mihir Solanki.
Intracellular Protein Degradation
Proteolysis Targeting Chimera Profacgen. In mammalian cells, protein degradation is mainly carried out by the ubiquitin- proteasome system to dispose.
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
Volume 13, Issue 13, Pages R514-R516 (July 2003)
Different ubiquitin linkage types and their role in immune signallingUbiquitin, a small protein of 76 amino acids, can be attached to a substrate protein.
Overview of the Control of the Cell Cycle
HUWE1 inhibition as a therapeutic strategy to target MYC in MM
Wavelength Tunability
Ligand Docking to MHC Class I Molecules
Schematic diagram of ubiquitin and SUMO modification pathways
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
Volume 19, Issue 4, Pages (April 2012)
Ubiquitin code assembly and disassembly
Deubiquitinating enzymes of proteasome.
Multivalency-Assisted Control of Intracellular Signaling Pathways: Application for Ubiquitin- Dependent N-End Rule Pathway  Shashikanth M. Sriram, Rajkumar.
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Alternative and aberrant splicing of MDM2 mRNA in human cancer
Volume 19, Issue 4, Pages (August 2005)
ZFAND5 enhanced basal ATPase activity and degradation of Ub conjugates by pure 26S proteasomes. ZFAND5 enhanced basal ATPase activity and degradation of.
ZFAND5 stimulates proteasomes and promotes overall protein degradation in MEF, HeLa, and HEK293 cells. ZFAND5 stimulates proteasomes and promotes overall.
Ubiquitin-proteasome systems in muscle homeostasis.
Protein regulation: Tag wrestling with relatives of ubiquitin
Volume 48, Issue 6, Pages (December 2012)
Discovery of Gö6976-related potent reversible EGFR T790M inhibitors.
Compartmentalized cellular functions of KDM4A.
Presentation transcript:

Characterization and Inhibitor Development of the Mammalian N-end Rule Pathway PACCON 2013 Jan. 24, 2013 Min Jae Lee Department of Applied Chemistry College of Applied Science Kyung Hee University, Korea

Protein Synthesis vs Degradation Foreign vs Body Protein degradation Extracellular vs Intracellular Protein degradation Autophagy-Lysosomal System (ALS) vs Ubiquitin-Proteasome System (UPS)

Ubiquitin (Ub) C-terminal Gly-Gly-COO - Ubiquitin (Ub) functions as a degradation signal Lys-NH 3 + Isopeptide bond - Ub structure

Target Protein Ubiquitin Ubiquitins (poly)ubiquitinated Proteasome (poly)ubiquitinated target substrate peptide fragments free Ub The Ubiquitin-Proteasome System (UPS)

Conjugation of poly-Ub chain to the substrates UPS (A Little More Details) E3 ubiquitin ligases Deubiquitinating enzymes Degradation of the tagged protein by the 26S proteasome

A Case Study: Proteasome Inhibitor as Cancer Drug - MG132 (Z-Leu-Leu-Leu-al), a proteasome inhibitor - Bortezomib, Velcade® FDA approved for multiple myeloma in 2003; survival from 10% to 40~50% First new therapy for MM since the early 60s Sales ~$2 billion/yr; >100,000 treated Price: $ per 3.5 mg vial

Nature Review Cancer (2011)

Screening for Small Molecule Inhibitors of Usp14 Ub-AMC Ub-AMC hydrolysis activity Ub Usp14 Inhibitor hits free AMC Usp14: endogenous Proteasome inhibitor

Where is the decision to degrade a protein made? rate- determinant “Passive” - Traditional view - Our view “Active” role of proteasome on Ub chain dynamics Lee et al, Nature 2010 Inhibitor (IU1) of inhibitor (Usp14) enhanced the activity of proteasome IU1 can potentially be used to eliminate toxic proteins

Rhomboidal Structure of the Ubiquitin-Proteasome System

Met- A Degradation Signal: the N-terminal Amino Acid Rapid proteolysis (= short half-lives) Ub UBR protein X substrate … Stable (= long half-lives) UBR proteins: N-end rule E3 ubiquitin ligases Start codon vs N-terminal methionine Some N-terminal residues

In Vitro Model System of the N-end Rule Pathway Ubiuqitin / Protein / Reference (UPR) technique Stabilization by dipeptide inhibitors Two types of primary destabilizing residues 35 S labeling Autoradiography Dipeptide inhibitors

Effect of D -form Dipeptides on UBR Protein Inhibition

with or without dipeptides Functional Proteomic Screening for Mammalian N-end Rule Substrate Lee et al, PNAS 2005

Regulator of G-protein Signaling proteins (RGS4, RGS5, and RGS16) High-Throughput Screening (HTS) from 18,000 cDNAs Collaboration with “Meso Scale Discovery” 42 candidates

Lee et al, PNAS 2008 Yanxialei et al, submitted Physiological Functions of the N-end Rule Pathway Lee et al, JBC 2012 Lee et al, PNAS 2005 Inhibitor development Cardiomyocyte proliferation Endogenous substrates

Classification of N-terminal Destabilizing Residues Quantification of in vitro degradation assay

In silico Computational Docking Analysis (Type 1)

In silico Computational Docking Analysis (Type 2)

Rationally Designed Intraheterovalent Inhibitors Chemical structures Conceptual model of a bivalent inhibitor Controls of RF-C11 Arg Phe Lys C11 UBR boxClpS box

In Vitro Effects of Bivalent Inhibitors Comparison of IC 50 RF-C11: 15.5  M Lys-Ala: 148  M Arg-Ala: 283  M RF-C11: 2.74  M Trp-Ala:  M Phe-Ala:  M Type 1Type 2

Bivalent inhibitors can be used for the study of biochemical mechanisms of UBR box proteins and physiological function of the N- end rule pathway RF-C11 provides chemical insight for developing better rationally designed N-end rule inhibitors RF-C11, a Rationally-designed Intraheterovalent Inhibitior RF-C11 showed ~ 20 times better inhibitory effects Lee et al, PNAS 2008 Optimization is on-going

Optimizing RF-Cn Linker Length

Free  -Amine and Peptide Bond Are Essential for N-degron Recognition

Monomeric Phe-derivatives Inhibited N-end Rule Pathway

Chloro-Amphetamine Delays Phe-nsP4 Degradation

UBR1 and its evolutionarily descendent UBR2 may have different specificity to N-degrons Recognition of N-degron is stereo-specific The optimal linker length of RF-Cn is n=5 Heterovalent N-end rule inhibitors are successfully applied to mammalian cells. alpha-Amine should be intact for effective inhibition Peptide bonds are not essential for inhibition (Phe-amide exhibits similar activity to Phe-Ala) Chloro-amphetamine has been identified as an effective N- end rule inhibitor Summary of Biochemical Understanding of the N-end Rule Pathway

Funded by - AHAF (American Health Assistant Foundation) postdoctoral grant, - Korea NRF (National Research Foundation) New Researcher Grant, - Kyung Hee University Fellow Grant - Korea NRF International Collaboration Grant - Korea Ministry of Health and Welfare (MHW) Alzheimer’s Disease Research Grant

Thank you!